A Retrospective Analysis of the Clinical and Economic Burden of Mitral Regurgitation in Italy Using Real-World Data
Untreated MR is associated with worse clinical outcomes and higher long-term resource use. These findings support early intervention strategies and highlight the need to improve access to care, especially for high-risk populations. Further studies are warranted to explore outpatient care and address treatment disparities.
Authors
- Matteo Vernia
- S. Giardina
- Paolo Sciattella (ORCID: https://orcid.org/0000-0002-8364-1895)
- Belén Martí-Sánchez
- Federico De Marco
Institutions
- University of Rome Tor Vergata (IT)
- Centro Cardiologico Monzino (IT)
- Edwards Lifesciences (Switzerland) (CH)
Publication Details
- Journal
- Clinical Drug Investigation
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1007/s40261-025-01459-2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Roma Tor Vergata